Cyclo3pss Financial Statements From 2010 to 2025
Cyclo3pss' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Cyclo3pss' valuation are provided below:Cyclo3pss does not presently have any fundamental signals for analysis.
This module can also supplement various Cyclo3pss Technical models . Check out the analysis of Cyclo3pss Correlation against competitors.
Check Cyclo3pss financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cyclo3pss' main balance sheet or income statement drivers, such as , as well as many indicators such as . Cyclo3pss financial statements analysis is a perfect complement when working with Cyclo3pss Valuation or Volatility modules.
Cyclo3pss |
Cyclo3pss Company Current Valuation Analysis
Cyclo3pss' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Cyclo3pss Current Valuation | 693.78 K |
Most of Cyclo3pss' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cyclo3pss is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Cyclo3pss has a Current Valuation of 693.78 K. This is 100.0% lower than that of the Healthcare sector and 99.99% lower than that of the Diagnostics & Research industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Cyclo3pss Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cyclo3pss's current stock value. Our valuation model uses many indicators to compare Cyclo3pss value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cyclo3pss competition to find correlations between indicators driving Cyclo3pss's intrinsic value. More Info.Cyclo3pss is number one stock in return on asset category among its peers. It also is number one stock in profit margin category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cyclo3pss' earnings, one of the primary drivers of an investment's value.About Cyclo3pss Financial Statements
Cyclo3pss shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Cyclo3pss investors may analyze each financial statement separately, they are all interrelated. The changes in Cyclo3pss' assets and liabilities, for example, are also reflected in the revenues and expenses on on Cyclo3pss' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Cyclo3pss Corporation engages in the licensing, manufacture, sale, and installation of ozone food processing products and ozone washing and laundry sorting and counting systems for commercial and institutional laundries. In July 2002, the Board of Directors of Cyclo3pss determined to suspend all operations of the company immediately due to an inability to locate willing investors and to secure necessary and suitable financing. CYCLOPSS CORP operates under Diagnostics Research classification in the United States and is traded on PNK Exchange. It employs 4 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Cyclo3pss Pink Sheet Analysis
When running Cyclo3pss' price analysis, check to measure Cyclo3pss' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cyclo3pss is operating at the current time. Most of Cyclo3pss' value examination focuses on studying past and present price action to predict the probability of Cyclo3pss' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cyclo3pss' price. Additionally, you may evaluate how the addition of Cyclo3pss to your portfolios can decrease your overall portfolio volatility.